Back to search
Respiratory Syncytial Viral (RSV) Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Respiratory Syncytial Viral (RSV) Infections trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Respiratory Syncytial Viral (RSV) Infections trials you may qualify forThe main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk…
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity o…
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive mec…
Antimicrobial resistance is one of the most urgent health threats of our time, and Norwegian hospitals were required to reduce the use of broad-spectrum antibio…
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obta…
The purpose of this study is to evaluate safety, tolerability and immunogenicity of mRNA-1345 in participants who have been previously vaccinated with either Ar…
Viral respiratory tract infections are very common in children. They contribute to missed time in school, work disruption for caregivers and can also cause seve…